Literature DB >> 26505821

Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women?

Pascale Chavassieux1, Nathalie Portero-Muzy1, Jean-Paul Roux1, Patrick Garnero1, Roland Chapurlat1.   

Abstract

CONTEXT: The levels of bone formation and resorption can be assessed at the tissue level by bone histomorphometry on transiliac bone biopsies. Systemic biochemical markers of bone turnover reflect the overall bone formation and resorption at the level of the entire skeleton but cannot discriminate the different skeletal compartments.
OBJECTIVE: Our aim was to investigate the correlations between the serum biochemical markers of formation and resorption with histomorphometric parameters.
DESIGN: We performed post hoc analysis of a previous clinical study.
SETTING: Patients were selected from the general population. PATIENTS: A total of 371 untreated postmenopausal osteoporotic women aged 50 to 84 years with a lumbar T-score ≤ -2.5 SD or ≤ -1 SD with at least one osteoporotic fracture.
INTERVENTIONS: Transiliac bone biopsies were obtained after a double tetracycline labeling, and blood samples were collected. MAIN OUTCOME MEASURES: The static and dynamic parameters of formation and bone resorption were measured by histomorphometry. Serum biochemical markers of formation (bone alkaline phosphatase [ALP]; procollagen type I N-terminal propeptide [PINP]) and resorption (C-terminal crosslinking telopeptide of collagen type 1 [sCTX]) were assessed.
RESULTS: The mean values of biochemical markers were: bone ALP, 15.0 ± 5.2 ng/mL; PINP, 56.2 ± 21.9 μg/mL; and sCTX, 0.58 ± 0.26 ng/mL. Bone ALP and PINP were significantly correlated with both the static and dynamic parameters of formation (0.21 ≤ r' ≤ 0.36; 0.01 ≥ P ≥ .0001). sCTX was significantly correlated with all resorption parameters (0.18 ≤ r' ≤ 0.24; 0.02 ≥ P ≥ .0001).
CONCLUSION: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not represent perfectly the whole bone turnover.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26505821     DOI: 10.1210/jc.2015-2957

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  28 in total

Review 1.  Biomarkers Predicting Bone Turnover in the Setting of CKD.

Authors:  Pieter Evenepoel; Etienne Cavalier; Patrick C D'Haese
Journal:  Curr Osteoporos Rep       Date:  2017-06       Impact factor: 5.096

Review 2.  Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability.

Authors:  P Szulc; K Naylor; N R Hoyle; R Eastell; E T Leary
Journal:  Osteoporos Int       Date:  2017-06-19       Impact factor: 4.507

3.  Distinct Clinical and Pathological Features of Melorheostosis Associated With Somatic MAP2K1 Mutations.

Authors:  Smita Jha; Nadja Fratzl-Zelman; Paul Roschger; Georgios Z Papadakis; Edward W Cowen; Heeseog Kang; Tanya J Lehky; Katharine Alter; Zuoming Deng; Aleksandra Ivovic; Lauren Flynn; James C Reynolds; Abhijit Dasgupta; Markku Miettinen; Eileen Lange; James Katz; Klaus Klaushofer; Joan C Marini; Richard M Siegel; Timothy Bhattacharyya
Journal:  J Bone Miner Res       Date:  2018-09-14       Impact factor: 6.741

4.  International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates.

Authors:  A Diez-Perez; K E Naylor; B Abrahamsen; D Agnusdei; M L Brandi; C Cooper; E Dennison; E F Eriksen; D T Gold; N Guañabens; P Hadji; M Hiligsmann; R Horne; R Josse; J A Kanis; B Obermayer-Pietsch; D Prieto-Alhambra; J-Y Reginster; R Rizzoli; S Silverman; M C Zillikens; R Eastell
Journal:  Osteoporos Int       Date:  2017-01-16       Impact factor: 4.507

5.  Bone Turnover Markers Are Not Associated With Hip Fracture Risk: A Case-Control Study in the Women's Health Initiative.

Authors:  Carolyn J Crandall; Sowmya Vasan; Andrea LaCroix; Meryl S LeBoff; Jane A Cauley; John A Robbins; Rebecca D Jackson; Douglas C Bauer
Journal:  J Bone Miner Res       Date:  2018-06-19       Impact factor: 6.741

6.  24-hour profile of serum sclerostin and its association with bone biomarkers in men.

Authors:  C Swanson; S A Shea; P Wolfe; S Markwardt; S W Cain; M Munch; C A Czeisler; E S Orwoll; O M Buxton
Journal:  Osteoporos Int       Date:  2017-07-26       Impact factor: 4.507

7.  Quantifying the Balance Between Total Bone Formation and Total Bone Resorption: An Index of Net Bone Formation.

Authors:  Albert Shieh; Weijuan Han; Shinya Ishii; Gail A Greendale; Carolyn J Crandall; Arun S Karlamangla
Journal:  J Clin Endocrinol Metab       Date:  2016-06-23       Impact factor: 5.958

8.  Bone Turnover Markers After Sleep Restriction and Circadian Disruption: A Mechanism for Sleep-Related Bone Loss in Humans.

Authors:  Christine M Swanson; Steven A Shea; Pamela Wolfe; Sean W Cain; Mirjam Munch; Nina Vujovic; Charles A Czeisler; Orfeu M Buxton; Eric S Orwoll
Journal:  J Clin Endocrinol Metab       Date:  2017-10-01       Impact factor: 5.958

9.  Effect of n-3 PUFA on extracellular matrix protein turnover in patients with psoriatic arthritis: a randomized, double-blind, placebo-controlled trial.

Authors:  Signe Holm Nielsen; Samra Sardar; Anne Sofie Siebuhr; Annette Schlemmer; Erik Berg Schmidt; Anne-Christine Bay-Jensen; Morten A Karsdal; Jeppe Hagstrup Christensen; Salome Kristensen
Journal:  Rheumatol Int       Date:  2021-04-22       Impact factor: 2.631

10.  Rapid suppression of bone formation marker in response to sleep restriction and circadian disruption in men.

Authors:  C M Swanson; W M Kohrt; P Wolfe; K P Wright; S A Shea; S W Cain; M Munch; N Vujović; C A Czeisler; E S Orwoll; O M Buxton
Journal:  Osteoporos Int       Date:  2019-08-24       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.